India to South Africa: Ondansetron Export Trade Route

The India to South Africa Ondansetron corridor is one of India's established pharmaceutical export routes, with 129 shipments documented worth a combined $7.0M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's ondansetron manufacturing sector.

Across 19 active suppliers, the average shipment value stands at $53.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 11.9%, placing it at rank #19 among India's top ondansetron export destinations globally.

On the import side, key buyers of Indian ondansetron in South Africa include RANBAXY PHARMACEUTICALS PTY LTD , RANBAXY PHARMACEUTICALS PTY LTD.,, RANBAXY PHARMACEUTICALS PTY LIMITED and 40 others. RANBAXY PHARMACEUTICALS PTY LTD is the single largest importer with 3 shipments valued at $1.8M USD.

India's ondansetron exports to South Africa are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED — together account for 69% of total trade value on this route. The average shipment value of $53.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as zofer rapitab 4 mg (ondansetron orally d and zofer rapitab tabs 8mg 1x10b za(ondansetron orally disintegrating tab 8 (pack :sp), suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, RANBAXY PHARMACEUTICALS PTY LTD is the largest importer with 3 shipments worth $1.8M USD — representing 25% of all ondansetron imports from India on this route. A total of 43 buyers are active on this corridor.